You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  VIGNETTES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Partial Lipodystrophy and Dermatomyositis

Antonio Torrelo, MD; Agustín España, MD; Pablo Boixeda, MD; Antonio Ledo, MD
Department of Dermatology Hospital "Ramón y Cajal" Apartado 37 28034-Madrid, Spain

Arch Dermatol. 1991;127(12):1846-1847.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

— Partial lipodystrophy (PL) is characterized by a slow and symmetrical loss of subcutaneous fatty tissue, mainly involving the upper half of the body. We report a case of PL associated with dermatomyositis.

Report of a Case.

— In 1978, an 11-year-old boy began to notice proximal weakness in his limbs together with facial erythema; palpebral violaceous edema; and erythematous papules on his elbows, knees, and over the metacarpophalangeal joints. A diagnosis of polymyositis/dermatomyositis was made. He was treated with oral prednisone, which caused the symptoms to disappear promptly. In 1980, proximal weakness, dysphagia, dyspnea, and similar cutaneous lesions once again developed. Muscular wasting and slight articular retractions were evident. Laboratory values at that time showed the following values or results: aspartate aminotransferase, 122 U/L (normal, 0 to 40 U/L); alanine aminotransferase, 140 U/L (normal, 0 to 40 U/L); creatine phosphokinase, 303 U/L (normal, 0 to 200 . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.